These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6711212)

  • 21. [Biological perturbations in affective disorders in man].
    Rafaelsen OJ
    Encephale; 1981; 7(4 Suppl):413-9. PubMed ID: 7318758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Various factors common to the pathogenesis of endogenous depression and chronic alcoholism].
    Nuller IuL; Ostroumova MN; Berezhnaia VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1375-9. PubMed ID: 7324694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance.
    Chiodini I; Di Lembo S; Morelli V; Epaminonda P; Coletti F; Masserini B; Scillitani A; Arosio M; Adda G
    Metabolism; 2006 Aug; 55(8):1135-40. PubMed ID: 16839852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Structural and dynamic analysis of affective disorders in alcoholism].
    Markovskaia NS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):58-61. PubMed ID: 1647629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.
    Reppermund S; Zihl J; Lucae S; Horstmann S; Kloiber S; Holsboer F; Ising M
    Biol Psychiatry; 2007 Sep; 62(5):400-6. PubMed ID: 17188252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
    Pfennig A; Kunzel HE; Kern N; Ising M; Majer M; Fuchs B; Ernst G; Holsboer F; Binder EB
    Biol Psychiatry; 2005 Feb; 57(4):336-42. PubMed ID: 15705348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression and endocrine disorders: focus on the thyroid and adrenal system.
    Musselman DL; Nemeroff CB
    Br J Psychiatry Suppl; 1996 Jun; (30):123-8. PubMed ID: 8864158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J; Lammers CH; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):797-802. PubMed ID: 8750037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients.
    Jokinen J; Nordström P
    Psychoneuroendocrinology; 2008 Nov; 33(10):1387-93. PubMed ID: 18805641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Affective disorders in alcoholic patients during periods of abstinence].
    Treskov VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):918-22. PubMed ID: 3751430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HPA-axis and immune function in burnout.
    Mommersteeg PM; Heijnen CJ; Kavelaars A; van Doornen LJ
    Prog Brain Res; 2008; 167():281-5. PubMed ID: 18037026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.
    Farren CK; O'Malley S; Grebski G; Maniar S; Porter M; Kreek MJ
    Alcohol Clin Exp Res; 1999 Mar; 23(3):502-8. PubMed ID: 10195825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and affective disorders in the elderly: a neuroendocrine study.
    Ferrari E; Mirani M; Barili L; Falvo F; Solerte SB; Cravello L; Pini L; Magri F
    Arch Gerontol Geriatr Suppl; 2004; (9):171-82. PubMed ID: 15207411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders.
    Watson S; Gallagher P; Ferrier IN; Young AH
    J Psychiatr Res; 2006 Jun; 40(4):353-9. PubMed ID: 16165159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affective symptoms in early-onset dementia.
    Podell K; Torres K
    Neurol Clin; 2011 Feb; 29(1):99-114, viii. PubMed ID: 21172573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic-pituitary-adrenal axis in schizophrenia.
    Altamura AC
    Biol Psychiatry; 1996 Sep; 40(6):560-1. PubMed ID: 8879482
    [No Abstract]   [Full Text] [Related]  

  • 40. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.